SCHEMBL5467653

SCHEMBL5467653

CC(C)(C)OC(=O)COc1ccc(CC(=O)O)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.43
FFAR1 O14842 4/20 0.42
MTNR1A P48039 2/20 0.41
MTNR1B P49286 2/20 0.41
ITGB1 P05556 2/20 0.41
ITGA4 P13612 2/20 0.41
PPARD Q03181 4/20 0.41
PPARA Q07869 4/20 0.41
PPARG P37231 2/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14431532 0.86 FFAR1 (0.41) FFAR1MTNR1AMTNR1BITGB1ITGA4
SCHEMBL5473946 0.83 MEN1 (0.48) GAAMTNR1AMTNR1BITGB1ITGA4
SCHEMBL24934106 0.80 AAK1 (0.40) MTNR1AMTNR1BALDH1A1TSHRPOLB
SCHEMBL8770380 0.80 AAK1 (0.40) MTNR1AMTNR1BALDH1A1TSHRPTGDR2
SCHEMBL24933585 0.80 AAK1 (0.57) GAAALDH1A1PTGDR2POLBMAPT
SCHEMBL926197 0.79 SCN9A (0.46) GAAPPARDAAK1
SCHEMBL12697638 0.77 PLA2G4B (0.56) PPARDRXRARXRBRXRGPOLB
SCHEMBL6581250 0.76 LMNA (0.42) MTNR1AMTNR1BMAPTCYP2C9CYP2C19
SCHEMBL964651 0.76 RXRA (0.48) GAAPPARDRXRARXRBRXRG
SCHEMBL5472921 0.76 PLA2G4B (0.57) FFAR1PPARDPPARAPPARGRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197626-A1 Indoline derivatives BAYER HEALTHCARE AG (DE) 2007-08-23 US disclosed
EP-1675825-A2 INDOLINE DERIVATIVES AS PPAR-DELTA MODULATORS Bayer HealthCare AG (DE) 2006-07-05 EP disclosed
WO-2005019169-A2 INDOLINE DERIVATIVES AS PPAR-DELTA MODULATORS BAYER HEALTHCARE AG (DE) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197626-A1 Indoline derivatives PPARD, PPARA, PPARG GAA 3390/4885FFAR1 104/4885MTNR1A 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.